Leila T. Alexander

Leila graduated with a degree in Medical Engineering in 2009, earned her doctorate in drug discovery from the University of Oxford in 2013, and gained post-doctoral experience in cancer metabolomics at ETH Zürich. With over 10 years of experience in bridging the gap between industry and academia, she has worked at Novartis, AstraZeneca, a software development startup, and a health economics consultancy. In 2017, she joined the SIB Swiss Institute of Bioinformatics, where she was responsible for setting up and managing the operations of the SPHN Data Coordination Centre and the BioMedIT project. Currently, she oversees scientific activities at the Computational Structural Biology group, and manages collaborations with academic and industrial partners.